Setting the Stage: Clinical Innovation from Boston and Beyond


Virtual  
Tuesday, February 01, 2022 7:00 PM - 8:30 PM   Add to Calendar Eastern Standard Time

Please join us for the first in our three-part series that is focused on introducing HBA members to the evolution of the life sciences industry over the past 20 years, and the leading role that Boston has played in it. Starting with The Human Genome Project, the latest cutting-edge innovations in genetic editing, precision medicines and AI all contribute to advancing the development of treatments for chronic and rare diseases. This series of HBA programs will explore what has driven the great strides made in therapeutic and disease advancement as well as how to adapt to the realities and dynamics of clinical development today. In this first event, explore the history from genetics to gene therapy in this fireside chat, moderated by Taren Grom, Editor in Chief Emeritus of Pharma Voice. Bob Coughlin, Managing Director of JLL's National Life Science Practice, and Wendy White, Board Member of ICHORD and former Chief Patent Officer of Vitrisa Therapeutics, will discuss the drivers and inspiration behind the clinical innovation that is needed to bring these inventive and life-changing therapies to patients.

HBA Boston presents

Setting the Stage: Clinical Innovation from Boston and Beyond


Date and time
Tuesday, 01 February
07:00PM - 08:30PM EST
Location
Virtual

Event Contact
Crystal Shih
Competencies
3. Exhibits business and industry acumen
Event Sponsor


Please join us for the first in our three-part series that is focused on introducing HBA members to the evolution of the life sciences industry over the past 20 years, and the leading role that Boston has played in it. Starting with The Human Genome Project, the latest cutting-edge innovations in genetic editing, precision medicines and AI all contribute to advancing the development of treatments for chronic and rare diseases. This series of HBA programs will explore what has driven the great strides made in therapeutic and disease advancement as well as how to adapt to the realities and dynamics of clinical development today.

In this first event, explore the history from genetics to gene therapy in this fireside chat, moderated by Taren Grom, Editor in Chief Emeritus of Pharma Voice. Bob Coughlin, Managing Director of JLL's National Life Science Practice and former CEO of Mass Bio, and Wendy White, former Chair of Global Genes and former Board Member for the National Organization for Rare Disorders, will discuss the drivers and inspiration behind the clinical innovation that is needed to bring these inventive and life-changing therapies to patients with rare diseases.


Registration information
Event is open to: HBA Members and Nonmembers

Cancellations/refunds
This event is refundable, requests must be submitted in writing to events@hbanet.org by 29 January 2022

Featured Speakers

Robert  Coughlin
Managing Director, National Life Science Practice
Jones Lang Lasalle (JLL)
Taren  Grom
co-founding partner/editor-in-chief
Wendy  White
Board Director
Learning Objectives
• Chart the evolution of the life sciences industry over the past 20 years.
• Identify key drivers and inspiration in tackling rare disease.
• Outline the challenges in developing medicines for rare disease.

Registration information

The registration button at the bottom of the page will not show if online registration has closed or if the event has reached capacity. If you are a guest and the registration button is not showing, it may be that this is a member-only event. Read more about the benefits of membership or contact us about membership.

The HBA will make reasonable modifications to policies and programs to ensure that people with special needs have an equal opportunity to enjoy all of its programs. Contact us if you require special accommodations for this event.

 Price LevelRegular
Collapse group

Registration: Regular Registration

 Member$10.00
 Member - Euro€8.00
 Non-Member$20.00
 Non-Member - Euro€17.00

By registering for this event, you acknowledge that you may be photographed, videotaped and/or audio-taped during the course of the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.